Netherlands Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

Netherlands Biomaterials in Healthcare Market Analysis

$ 3999

The Netherlands Biomaterials in Healthcare Market is expected to witness growth from $406 Mn in 2022 to $1135 Mn in 2030 with a CAGR of 13.70% for the forecasted year 2022-2030. The demand for biomaterials in Netherlands is being driven by the emerging tendency of "personalized medicine" in the healthcare sector. Personalized medical devices and treatments that are catered to the requirements of each patient are being developed using biomaterials. The market is segmented by type and by application. Some key players in this market include: Hy2Care B.V, InnoSer, DSM N.V, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10NLMD003 CATEGORY: Medical Devices GEOGRAPHY: Netherlands

Buy Now

Netherlands Biomaterials in Healthcare Market Executive Analysis

The Netherlands Biomaterials in Healthcare Market size is at around $406 Mn in 2022 and is projected to reach $1135 Mn in 2030, exhibiting a CAGR of 13.70% during the forecast period. In the Netherlands, healthcare costs accounted for 10.5% of GDP, and together, co-payments (11%), general taxation (22%), employer-paid salary taxes (46%), and general taxation (22%) covered 81% of that expense. The Netherlands spent $5.33 Mn per individual on healthcare in 2019. From $3.03 Mn in 2015 to $6 Mn in 2022, the Netherlands' health spending grew at a cumulative annual growth rate of 5.64%.

In Netherlands, Because of their versatility and distinctive qualities, biomaterials are being used more frequently in the Netherlands' healthcare sector. In the design and manufacture of medical devices, tissue engineering, drug delivery, and other healthcare uses, biomaterials are materials that interact with biological systems are frequently used. Medical devices like implantable devices, prosthetic limbs, and surgical tools are created using biomaterials. They offer a biocompatible surface, lowering the possibility of rejection and fostering the device's fusion with the nearby tissue. In tissue engineering, biomaterials are used to build scaffolds that help new tissue develop. These scaffolds can be created to closely resemble the natural composition and characteristics of the tissue that is being rebuilt, leading to better results and quicker recovery periods. Drugs can be delivered directly to the site of an injury or illness using biomaterials. This method of targeted drug delivery lowers the quantity of medication needed and lowers the possibility of side effects.

netherlands biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

Sustainable biomaterials are increasingly in demand in the Netherlands healthcare sector. Manufacturers who can create environmentally friendly, sustainable biomaterials will probably have an edge over competitors. The demand for biomaterials in Netherlands is being driven by the emerging tendency of "personalized medicine" in the healthcare sector. Personalized medical devices and treatments that are catered to the requirements of each patient are being developed using biomaterials. The demand for biomaterials is being driven by the aging populace in the Netherlands. Older people are more apt to need biomaterial-based medical procedures like joint replacements. Innovation and the creation of new products are being driven by technological advancements in the area of biomaterials. New biomaterials and medical devices are being developed as a result, which could improve patient outcomes and lower healthcare expenses. In the Netherlands, the frequency of lengthy-term illnesses like high blood pressure and diabetes is rising. To create novel medications and medical equipment that can enhance the management of these diseases, biomaterials are being used, which leads to market growth in the Netherlands Biomaterials in Healthcare market.

Market Restraints

In Netherlands, it can be expensive and time-consuming to develop and market biomaterials for medical uses. Research and development, clinical trials, and regulatory approvals may require manufacturers to spend a substantial amount of money, which can have an effect on profitability. Many health care providers and patients in the Netherlands might not be familiar with the advantages of or how they operate with biomaterials because it is a relatively new and complicated field of medicine. To market their goods and increase demand, Netherlands manufacturers of biomaterials may need to spend money on education and awareness campaigns.

Competitive Landscape

Key Players

Hy2Care B.V. (NL)
InnoSer (NL)
DSM N.V. (NL)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Recent Notable Deals

2022: A joint partnership between DSM and the Korean healthcare provider Kolon Life Science was established in 2022 with the goal of creating cutting-edge biomaterials and medical equipment.

Healthcare Policies and Regulatory Landscape

The regulatory system for biomaterials is well-established in the Netherlands. The Dutch Healthcare Inspectorate is the regulating body in charge of monitoring medical equipment and biomaterials. (IGJ). The greatest levels of safety and effectiveness must be met by medical devices and biomaterials, according to IGJ. To regulate medical devices and biomaterials, the Dutch government created the Medical Devices Act (Wet op de Medische Hulpmiddelen). All medical equipment and biomaterials must adhere to stringent safety, efficacy, and quality requirements under this law. Before being sold in the Netherlands, medical gadgets and biomaterials must be registered with the IGJ. The Netherlands' Biomaterials in Healthcare industry is subject to the EU's regulatory framework. Medical devices and biomaterials must adhere to stringent guidelines outlined in the EU's Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). The rules are designed to provide patients and users of medical equipment and biomaterials in the EU with a high degree of protection.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Netherlands market in 2019. The growing geriatric population Netherlandsly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.